• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A comparison of liver disease mortality with HIV and overdose mortality among Georgia prisoners and releasees: a 2-decade cohort study of prisoners incarcerated in 1991.佐治亚州囚犯及获释人员中肝病死亡率与艾滋病毒及药物过量死亡率的比较:对1991年入狱囚犯的20年队列研究
Am J Public Health. 2015 May;105(5):e51-7. doi: 10.2105/AJPH.2014.302546. Epub 2015 Mar 19.
2
Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.纳洛酮缓释剂预防出狱后阿片类药物过量死亡的随机对照试验性研究
Addiction. 2017 Mar;112(3):502-515. doi: 10.1111/add.13668. Epub 2016 Dec 13.
3
[Mortality of drug users attending public treatment centers in Italy 1998-2001: a cohort study].[1998 - 2001年意大利公共治疗中心吸毒者的死亡率:一项队列研究]
Epidemiol Prev. 2007 Sep-Oct;31(5):276-82.
4
The increasing mortality burden of liver disease among opioid-dependent people: cohort study.阿片类药物依赖者中肝病死亡率负担增加:队列研究。
Addiction. 2011 Dec;106(12):2186-92. doi: 10.1111/j.1360-0443.2011.03575.x. Epub 2011 Oct 17.
5
Characterization of drug overdoses in an Ohio incarcerated population.俄亥俄州监狱人群药物过量情况的特征分析
Clin Toxicol (Phila). 2016 Mar;54(3):266-70. doi: 10.3109/15563650.2015.1135338. Epub 2016 Jan 21.
6
Release from prison--a high risk of death for former inmates.出狱—— former inmates 面临高死亡风险。 (注:“former inmates”直译为“前囚犯”,结合语境可灵活处理为“出狱人员”等更符合中文表达习惯的表述,但按照要求不能添加解释,所以保留英文)
N Engl J Med. 2007 Jan 11;356(2):157-65. doi: 10.1056/NEJMsa064115.
7
Mortality from overdose among injecting drug users recently released from prison: database linkage study.近期刑满释放的注射吸毒者过量用药死亡率:数据库关联研究
BMJ. 1998 Feb 7;316(7129):426-8. doi: 10.1136/bmj.316.7129.426.
8
Retrospective cohort study of cancer incidence and mortality by HIV status in a Georgia, USA, prisoner cohort during the HAART era.在高效抗逆转录病毒治疗(HAART)时代,对美国佐治亚州一个囚犯队列中按艾滋病毒感染状况划分的癌症发病率和死亡率进行回顾性队列研究。
BMJ Open. 2016 Apr 11;6(4):e009778. doi: 10.1136/bmjopen-2015-009778.
9
Acute risk of drug-related death among newly released prisoners in England and Wales.英格兰和威尔士新获释囚犯中与药物相关死亡的急性风险。
Addiction. 2008 Feb;103(2):251-5. doi: 10.1111/j.1360-0443.2007.02081.x.
10
Risk factors for all-cause, overdose and early deaths after release from prison in Washington state.华盛顿州囚犯出狱后全因、过量用药和早期死亡的风险因素。
Drug Alcohol Depend. 2011 Aug 1;117(1):1-6. doi: 10.1016/j.drugalcdep.2010.11.029. Epub 2011 Feb 3.

引用本文的文献

1
The Efficacy of On-Site Integration Screening and Microelimination Programs for Chronic Hepatitis C in a Detection Center: A Comparison of the Treatment Outcomes and Characteristics of Incarcerated Patients and Outpatients.某检测中心慢性丙型肝炎现场综合筛查及微消除项目的疗效:监禁患者与门诊患者治疗结果及特征的比较
Int J Hepatol. 2024 Mar 13;2024:3184892. doi: 10.1155/2024/3184892. eCollection 2024.
2
Record linkage studies of drug-related deaths among adults who were released from prison to the community: a scoping review.监狱释放成年人药物相关死亡的记录链接研究:范围综述。
BMC Public Health. 2023 May 5;23(1):826. doi: 10.1186/s12889-023-15673-0.
3
Stakeholder-engaged research is necessary across the criminal-legal spectrum.在整个刑事法律领域,利益相关者参与的研究是必要的。
J Clin Transl Sci. 2022 Nov 15;7(1):e5. doi: 10.1017/cts.2022.501. eCollection 2023.
4
Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.马来西亚一项随机、参与者选择、开放性标签试验结果:出狱后,美沙酮预先发放对艾滋病毒和阿片类药物使用障碍者死亡率的影响。
BMC Infect Dis. 2022 Nov 11;22(1):837. doi: 10.1186/s12879-022-07804-6.
5
Incarceration status and cancer mortality: A population-based study.监禁状况与癌症死亡率:一项基于人群的研究。
PLoS One. 2022 Sep 16;17(9):e0274703. doi: 10.1371/journal.pone.0274703. eCollection 2022.
6
Violence-related deaths among people released from incarceration: systematic review and meta-analysis of cohort studies.出狱人员中与暴力相关的死亡:队列研究的系统评价和荟萃分析
EClinicalMedicine. 2021 Oct 24;41:101162. doi: 10.1016/j.eclinm.2021.101162. eCollection 2021 Nov.
7
Fatal overdoses after release from prison in British Columbia: a retrospective data linkage study.不列颠哥伦比亚省监狱释放后致死性过量用药:回顾性数据链接研究。
CMAJ Open. 2021 Sep 28;9(3):E907-E914. doi: 10.9778/cmajo.20200243. Print 2021 Jul-Sep.
8
Commentary on Victor et al. : Preventing overdose deaths following release from incarceration-context is crucial.对维克多等人的评论:监禁释放后预防过量用药死亡——背景至关重要。
Addiction. 2022 Feb;117(2):442-443. doi: 10.1111/add.15679. Epub 2021 Sep 21.
9
Disparities in cancer prevalence, incidence, and mortality for incarcerated and formerly incarcerated patients: A scoping review.囚犯和前囚犯的癌症患病率、发病率和死亡率的差异:范围综述。
Cancer Med. 2021 Oct;10(20):7277-7288. doi: 10.1002/cam4.4251. Epub 2021 Sep 3.
10
Violence-related deaths among people released from incarceration: protocol for a systematic review.监禁释放人群中与暴力相关的死亡:系统评价方案。
BMJ Open. 2021 Jan 20;11(1):e045601. doi: 10.1136/bmjopen-2020-045601.

本文引用的文献

1
Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: a cost-effectiveness analysis.基于索非布韦的治疗方案用于美国监狱人群慢性1型丙型肝炎病毒感染的成本效益分析
Ann Intern Med. 2014 Oct 21;161(8):546-53. doi: 10.7326/M14-0602.
2
Treatment of hepatitis C: a systematic review.丙型肝炎的治疗:系统评价。
JAMA. 2014 Aug 13;312(6):631-40. doi: 10.1001/jama.2014.7085.
3
Striking subgroup differences in substance-related mortality after release from prison.从监狱获释后,与物质相关的死亡率存在显著的亚组差异。
Addiction. 2014 Oct;109(10):1676-83. doi: 10.1111/add.12646. Epub 2014 Jul 2.
4
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.美国慢性丙型肝炎病毒感染,2003 年至 2010 年全国健康和营养调查。
Ann Intern Med. 2014 Mar 4;160(5):293-300. doi: 10.7326/M13-1133.
5
Hepatitis C seroprevalence among prison inmates since 2001: still high but declining.自 2001 年以来监狱囚犯中的丙型肝炎血清流行率:仍然很高但呈下降趋势。
Public Health Rep. 2014 Mar-Apr;129(2):187-95. doi: 10.1177/003335491412900213.
6
Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.无干扰素治疗丙型肝炎病毒基因型 1 的 2b 期临床试验。
N Engl J Med. 2014 Jan 16;370(3):222-32. doi: 10.1056/NEJMoa1306227.
7
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.达卡他韦联合索非布韦治疗既往治疗或未经治疗的慢性 HCV 感染。
N Engl J Med. 2014 Jan 16;370(3):211-21. doi: 10.1056/NEJMoa1306218.
8
Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.成人丙型肝炎病毒感染筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2013 Sep 3;159(5):349-57. doi: 10.7326/0003-4819-159-5-201309030-00672.
9
Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.出狱后携带急救纳洛酮预防海洛因过量死亡:N-ALIVE 随机试验的原理和实用性。
J Urban Health. 2013 Oct;90(5):983-96. doi: 10.1007/s11524-013-9803-1.
10
Sofosbuvir for previously untreated chronic hepatitis C infection.索磷布韦片治疗未经治疗的慢性丙型肝炎感染。
N Engl J Med. 2013 May 16;368(20):1878-87. doi: 10.1056/NEJMoa1214853. Epub 2013 Apr 23.

佐治亚州囚犯及获释人员中肝病死亡率与艾滋病毒及药物过量死亡率的比较:对1991年入狱囚犯的20年队列研究

A comparison of liver disease mortality with HIV and overdose mortality among Georgia prisoners and releasees: a 2-decade cohort study of prisoners incarcerated in 1991.

作者信息

Spaulding Anne C, Sharma Akshay, Messina Lauren C, Zlotorzynska Maria, Miller Lesley, Binswanger Ingrid A

机构信息

At the time of the study, Anne C. Spaulding, Lauren C. Messina, and Maria Zlotorzynska were with and Akshay Sharma was a doctoral student in the Department of Epidemiology, Rollins School of Public Health, and Lesley Miller was with the Division of General Medicine, School of Medicine, Emory University, Atlanta, GA. Ingrid A. Binswanger is with the University of Colorado School of Medicine, Aurora.

出版信息

Am J Public Health. 2015 May;105(5):e51-7. doi: 10.2105/AJPH.2014.302546. Epub 2015 Mar 19.

DOI:10.2105/AJPH.2014.302546
PMID:25790417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4386519/
Abstract

OBJECTIVES

We investigated whether eventual causes of death among a cohort of inmates imprisoned in the southeastern United States differed from those in previous prisoner studies.

METHODS

We matched 23 510 prisoners in Georgia, a state with historically low levels of heroin consumption but moderate amounts of injection drug use, who were incarcerated on June 30, 1991, to death registries through 2010. Main exposure was 4-year time intervals over 2 decades of observation; main outcome was mortality from liver disease, HIV, and overdose.

RESULTS

Although the HIV-related mortality rate exceeded that from liver-related conditions before 2003, liver disease subsequently surpassed HIV as a cause of death. Among 3863 deaths, 22 (0.6%) occurred within 2 weeks after release from prison. Of these, only 2 were caused by accidental poisoning (likely drug overdose). Cardiovascular disease and cancer were the most frequent causes of death in this aging cohort.

CONCLUSIONS

Our study design deemphasized immediate deaths but highlighted long-term sequelae of exposure to viral hepatitis and alcohol. Treating hepatitis C and implementing interventions to manage alcohol use disorders may improve survival among prisoners in the Southeast.

摘要

目的

我们调查了美国东南部一群囚犯的最终死因是否与以往囚犯研究中的死因不同。

方法

我们将1991年6月30日被监禁在佐治亚州的23510名囚犯与2010年之前的死亡登记册进行匹配,佐治亚州历史上海洛因消费量较低,但注射吸毒量适中。主要暴露因素是20年观察期内的4年时间间隔;主要结局是肝病、艾滋病毒和药物过量导致的死亡率。

结果

尽管2003年之前与艾滋病毒相关的死亡率超过了与肝脏相关疾病的死亡率,但肝病随后超过艾滋病毒成为死因。在3863例死亡中,22例(0.6%)在出狱后2周内发生。其中,只有2例是由意外中毒(可能是药物过量)引起的。心血管疾病和癌症是这个老龄化队列中最常见的死因。

结论

我们的研究设计淡化了即时死亡,但强调了接触病毒性肝炎和酒精的长期后遗症。治疗丙型肝炎并实施管理酒精使用障碍的干预措施可能会提高东南部囚犯的生存率。